miRNA는 20-30-뉴클레오티드 길이의 작은 비암호화 RNA 분자이며 유전자 조절에 중요한 역할을 합니다. 메신저 RNA(mRNA)에 부분적으로 상보적이기 때문에 중요한 세포 기능의 핵심 컨트롤러가 되는 유전자 발현을 하향 조절하는 주요 기능을 합니다. miRNA는 바이러스 감염, 자가면역 질환 및 발암과 같은 병리학적 과정과 관련이 있습니다. 따라서 새로운 miRNA를 식별하기 위해 광범위한 연구가 수행되고 있습니다. miRNA 시퀀싱 및 분석 시장의 성장은 주로 miRNA 응용 범위 확대 및 게놈 연구 자금 증가와 같은 요인에 기인합니다. 그러나 miRNA 기반 치료제의 전달, 효능 및 특이성과 관련된 문제는 시장 성장을 저지할 것으로 예상됩니다.
miRNA 시퀀싱 및 분석 시장의 유리한 지역
시장 통찰력
MicroRNA 응용 범위 확대
miRNA는 20-30개 뉴클레오티드 길이의 비암호화 및 작은 RNA 분자 그룹입니다. 이 분자는 표적 메신저 RNA(mRNA)에 결합하여 유전자 침묵을 유도하여 유전자 발현을 제어합니다. 따라서 이들은 세포 생리 및 발달에 중요한 역할을 합니다. miRNA는 세포 증식, 분화 및 세포 사멸과 같은 모든 세포 기능을 조절합니다. 분화 과정에 관여하여 조직 정체성을 제공하는 데 중요한 역할을 합니다. 따라서 miRNA는 세포 유형을 식별하는 데 유용한 마커로 생각됩니다.
또한 miRNA는 바이러스 감염, 자가 면역 질환 및 발암과 같은 병리학적 과정과도 관련이 있습니다. 그들 중 일부는 종양유전자(oncomiRs)로 작용할 수 있고, 다른 몇몇은 종양 억제 miRNA로 작용할 수 있습니다. miRNA의 변경된 발현은 다양한 유형의 암 발생과 관련이 있습니다. 새로운 종류의 암 바이오마커로서 차세대 시퀀싱 기술과 결합된 miRNA의 잠재력이 탐구되고 있습니다. 그들은 암의 발달, 진행, 예후, 진단 및 치료를 평가하는 데 중요한 역할을 할 것으로 예측됩니다. 또한 miRNA의 여러 종류는 HIV, 헨드라 바이러스, 결핵 및 말라리아를 포함하여 병원균에 의해 발생하는 감염성 질병에 대한 유망한 바이오마커로 부상했습니다. miRNA는 새로운 치료 접근법의 핵심 표적입니다. 암 및 간염과 같은 질병에 대한 여러 miRNA 표적 치료제가 임상 단계에 도달했습니다. 예를 들어, Santaris Pharma는 C형 간염 바이러스(HCV) 감염 치료를 위해 miR-122를 표적으로 하는 Miravirsen이라는 치료 분자를 개발했습니다. 분자는 2상 임상 시험에 있습니다. 따라서 miRNA의 응용 범위가 확대되면서 miRNA 시퀀싱 및 분석 시장의 성장을 주도하고 있습니다.
제품 기반 통찰력
miRNA 시퀀싱 및 분석 시장은 제품별로 라이브러리 준비 및 소모품으로 분류됩니다. 소모품 부문은 2019년에 시장에서 더 큰 점유율을 차지한 반면, 라이브러리 준비 부문은 예측 기간 동안 시장에서 더 높은 CAGR을 기록할 것으로 예상됩니다.
miRNA 시퀀싱 및 분석 시장, 제품별 - 2019 and 2027
기술 기반 통찰력
기술 기반 miRNA 시퀀싱 및 분석 시장은 합성, 나노포어 및 이온 반도체 시퀀싱에 의한 시퀀싱으로 세분화됩니다. 합성 세그먼트에 의한 시퀀싱은 2019년 시장에서 가장 큰 점유율을 차지했습니다. 그러나 nanopore 세그먼트는 2020-2027년 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.
최종 사용자 기반 통찰력
최종 사용자 기준, miRNA 시퀀싱 및 분석 시장 연구소, 학계, CRO로 구분됩니다. 연구 기관 부문은 2019년에 시장에서 가장 큰 점유율을 차지했으며 2020-2027년 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.
전략적 통찰력
협업은 miRNA 시퀀싱 및 분석 시장 참여자가 전 세계적으로 고객 기반을 확대하기 위해 채택한 주요 전략으로 브랜드 이름을 전 세계적으로 유지할 수 있습니다.
miRNA 시퀀싱 및 분석 시장 - 제품별
- 라이브러리 준비
- 소모품
miRNA 시퀀싱 및 분석 시장 - 기술별
- 합성 시퀀싱
- 이온 반도체 시퀀싱
< li>Nanopore
최종 사용자별 miRNA 시퀀싱 및 분석 시장
- 연구소
- CRO
< li>학술
miRNA 시퀀싱 및 분석 시장 – 지역별
- 북미
- US< /li>
- 캐나다
- 멕시코
- 유럽
- 프랑스
- 독일
- 이탈리아
- 영국
- 스페인
- 기타 유럽
- 아시아 태평양(APAC)
- 중국
- 인도
- 한국
- 일본
- 호주
- 기타 아시아 태평양
- 중동 및 아프리카(MEA)
- 남아프리카
- 사우디아라비아
- UAE
- 중동 및 아프리카의 나머지 지역
- 중남미
- 브라질
- 아르헨티나
< li>나머지 중남미
회사 프로필
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Perkin Elmer Inc.
- Takara Bio Inc.
- New England Biolabs
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- Lexogen GmbH
- Oxford Nanopore Technologies
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
miRNA is a small non-coding RNA molecule of 20–30-nucleotide length, and it plays an important role in gene regulation. As it is partially complementary to messenger RNA (mRNA), it serves a major function of down-regulating the gene expression, which makes it a key controller of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs.
The growth of the miRNA sequencing and assay market is mainly attributed to the factors such widening range of miRNA applications and rise in funding for genomics research. However, challenges related to delivery, efficacy, and specificity of miRNA-based therapeutics is projected to deter the market growth.
The GMP cytokines market majorly consists of the players such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Perkin Elmer, Inc., Takara Bio Inc., New England Biolabs, Norgen Biotek Corp, TriLink BioTechnologies Inc, Lexogen GmbH, and Oxford Nanopore Technologies among others.
The List of Companies - MiRNA Sequencing And Assay Market
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Perkin Elmer Inc.
- Takara Bio Inc.
- New England Biolabs
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- Lexogen GmbH
- Oxford Nanopore Technologies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)